SCHEMBL6920044

SCHEMBL6920044

CC(O)c1c(F)cncc1-c1cc2c(F)c(Cl)ccc2o1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.65
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32
GABRE P78334 1/20 0.32
GABRA6 Q16445 1/20 0.32
GABRG1 Q8N1C3 1/20 0.32
GABRG3 Q99928 1/20 0.32
GABRQ Q9UN88 1/20 0.32
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921318 0.80 CYP11B2 (0.73) CYP11B2GABRPGABRDGABRA1GABRB1
SCHEMBL14225077 0.79 CYP11B2 (0.40) CYP11B2GABRPGABRDGABRA1GABRB1
SCHEMBL6921215 0.79 CYP11B2 (1.00) CYP11B2
SCHEMBL14151820 0.78 CYP11B2 (0.73) CYP11B2GABRPGABRDGABRA1GABRB1
SCHEMBL6921831 0.73 CYP11B2 (0.62) CYP11B2
SCHEMBL14152255 0.70 CYP11B2 (0.62) CYP11B2
SCHEMBL18393034 0.67 CYP11B2 (0.50) CYP11B2PRKDCKCNH2
SCHEMBL26916398 0.65 CYP11B2 (0.45) CYP11B2
SCHEMBL26916402 0.65 CYP11B2 (0.45) CYP11B2
SCHEMBL26917406 0.65 CYP11B2 (0.45) CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501678-B1 ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2015-09-23 EP disclosed
WO-2011061168-A1 ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2011-05-26 WO disclosed